theraflu grip miód i cytryna 500 mg proszek do sporządzania roztworu doustnego
haleon poland sp. z o.o. - paracetamolum - proszek do sporządzania roztworu doustnego - 500 mg
theraflu extragrip 650 mg + 10 mg + 20 mg proszek do sporządzania roztworu doustnego
haleon poland sp. z o.o. - paracetamolum + phenylephrini hydrochloridum + pheniramini maleas - proszek do sporządzania roztworu doustnego - 650 mg + 10 mg + 20 mg
theraflu zatoki 650 mg + 10 mg proszek do sporządzania roztworu doustnego
haleon poland sp. z o.o. - paracetamolum + phenylephrini hydrochloridum - proszek do sporządzania roztworu doustnego - 650 mg + 10 mg
theraflu zatoki max 500 mg + 30 mg tabletki powlekane
glaxosmithkline consumer healthcare sp. z o.o. - paracetamolum + pseudoephedrini hydrochloridum - tabletki powlekane - 500 mg + 30 mg
theraflu kaszel 1,5 mg/ml syrop
glaxosmithkline consumer healthcare sp. z o.o. - butamirati citras - syrop - 1,5 mg/ml
theraflu przeziębienie (500 mg + 30 mg)/30 ml syrop
glaxosmithkline consumer healthcare sp. z o.o. - paracetamolum; pseudoephedrini hydrochloridum - syrop - (500 mg + 30 mg)/30 ml
theraflu complexgrip (500 mg + 10 mg + 200 mg)/30 ml syrop
glaxosmithkline consumer healthcare sp. z o.o. - paracetamolum + phenylephrini hydrochloridum + gwajafenezyna - syrop - (500 mg + 10 mg + 200 mg)/30 ml
theraflu max grip 1000 mg + 70 mg + 10 mg proszek do sporządzania roztworu doustnego
glaxosmithkline consumer healthcare sp. z o.o. - paracetamolum + acidum ascorbicum + phenylephrini hydrochloridum - proszek do sporządzania roztworu doustnego - 1000 mg + 70 mg + 10 mg
theraflu max grip 1000 mg + 10 mg + 70 mg proszek do sporządzania roztworu doustnego
haleon poland sp. z o.o. - paracetamolum + phenylephrini hydrochloridum + acidum ascorbicum - proszek do sporządzania roztworu doustnego - 1000 mg + 10 mg + 70 mg
pyrukynd
agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.